Cargando…

Adaptive Features of Natural Killer Cells in Multiple Sclerosis

Human cytomegalovirus (HCMV) has been recently related with a lower susceptibility to multiple sclerosis (MS). HCMV promotes an adaptive development of NK cells bearing the CD94/NKG2C receptor with a characteristic phenotypic and functional profile. NK cells are proposed to play an immunoregulatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreira, Antía, Alari-Pahissa, Elisenda, Munteis, Elvira, Vera, Andrea, Zabalza, Ana, Llop, Mireia, Villarrubia, Noelia, Costa-García, Marcel, Álvarez-Lafuente, Roberto, Villar, Luisa María, López-Botet, Miguel, Martínez-Rodríguez, Jose E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803486/ https://www.ncbi.nlm.nih.gov/pubmed/31681293 http://dx.doi.org/10.3389/fimmu.2019.02403

Ejemplares similares

Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis
por: Zabalza, Ana, et al.
Publicado: (2020)

Delayed B cell repopulation after rituximab treatment in multiple sclerosis patients with expanded adaptive natural killer cells
por: Moreira, Antía, et al.
Publicado: (2022)

Adaptations of Natural Killer Cells to Self-MHC Class I
por: Bessoles, Stéphanie, et al.
Publicado: (2014)

NK cells eliminate Epstein-Barr virus bound to B cells through a specific antibody-mediated uptake
por: Alari-Pahissa, Elisenda, et al.
Publicado: (2021)

The Conserved Non-Coding Sequence 2 (CNS2) Enhances CD69 Transcription through Cooperation between the Transcription Factors Oct1 and RUNX1
por: Fontela, Miguel G., et al.
Publicado: (2019)

Activation by SLAM Family Receptors Contributes to NK Cell Mediated “Missing-Self” Recognition
por: Alari-Pahissa, Elisenda, et al.
Publicado: (2016)

Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression
por: Pérez-Pérez, Silvia, et al.
Publicado: (2021)

Natural Killer receptors distribution in Multiple Sclerosis
por: Martinez-Rodriguez, J E, et al.
Publicado: (2010)

Mitochondrial Impairments in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients
por: Domínguez-Mozo, María Inmaculada, et al.
Publicado: (2022)

CD69 Does Not Affect the Extent of T Cell Priming
por: Alari-Pahissa, Elisenda, et al.
Publicado: (2012)

Acetate correlates with disability and immune response in multiple sclerosis
por: Pérez-Pérez, Silvia, et al.
Publicado: (2020)

MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists
por: Espinosa-Gil, Sergio, et al.
Publicado: (2023)

Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response
por: Domínguez-Mozo, María Inmaculada, et al.
Publicado: (2023)

Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls
por: Dominguez-Mozo, Maria Inmaculada, et al.
Publicado: (2021)

Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab
por: Dominguez-Mozo, Maria Inmaculada, et al.
Publicado: (2020)

Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients
por: Medina, Silvia, et al.
Publicado: (2019)

Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome
por: Monreal, Enric, et al.
Publicado: (2021)

The Forgotten Gastrointestinal Tract in COVID-19 Infection
por: Pedro-Botet, Juan, et al.
Publicado: (2020)

Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis
por: Ortiz, Miguel A., et al.
Publicado: (2015)

Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
por: Monreal, Enric, et al.
Publicado: (2023)

Pulmonary eosinophilia associated to treatment with natalizumab
por: Curto, Elena, et al.
Publicado: (2016)

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis
por: Picón, Carmen, et al.
Publicado: (2021)

Hydrophilic or Lipophilic Statins?
por: Climent, Elisenda, et al.
Publicado: (2021)

Familial Hypercholesterolemia: Do HDL Play a Role?
por: Pedro-Botet, Juan, et al.
Publicado: (2021)

Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment
por: Walo-Delgado, Paulette Esperanza, et al.
Publicado: (2021)

Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients
por: Pascual-Guardia, Sergi, et al.
Publicado: (2020)

Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies
por: Sainz de la Maza, Susana, et al.
Publicado: (2023)

Metabolomic signatures associated with disease severity in multiple sclerosis
por: Villoslada, Pablo, et al.
Publicado: (2017)

HHV-6 and Multiple Sclerosis
por: Jeanne Billioux, Bridgette, et al.
Publicado: (2014)

Bariatric Surgery and Hypertension
por: Climent, Elisenda, et al.
Publicado: (2021)

Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells
por: Mena, Jorge, et al.
Publicado: (2022)

Regulatory Functions of Natural Killer Cells in Multiple Sclerosis
por: Gross, Catharina C., et al.
Publicado: (2016)

Natural Killer Cells in Multiple Sclerosis: Entering the Stage
por: Beliën, Jarne, et al.
Publicado: (2022)

Molecular signature associated with cladribine treatment in patients with multiple sclerosis
por: Fissolo, Nicolas, et al.
Publicado: (2023)

The Role of Natural Killer Cells in Multiple Sclerosis and Their Therapeutic Implications
por: Chanvillard, Coralie, et al.
Publicado: (2013)

Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation
por: López-Botet, Miguel, et al.
Publicado: (2017)

Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab
por: Walo-Delgado, Paulette Esperanza, et al.
Publicado: (2021)

Priming of NK Cell Anti-Viral Effector Mechanisms by Direct Recognition of Human Cytomegalovirus
por: Muntasell, Aura, et al.
Publicado: (2013)

Natural Killer Cells in Immunotherapy: Are We Nearly There?
por: Bachiller, Mireia, et al.
Publicado: (2020)

Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes
por: Costa-García, Marcel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dghs9vbnjc5vdupas3h6c1m10h